| Title |
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis
|
|---|---|
| Published in |
Health technology assessment : HTA / NHS R & D HTA Programme., October 2013
|
| DOI | 10.3310/hta17440 |
| Pubmed ID | |
| Authors |
S Ward, A Scope, R Rafia, A Pandor, S Harnan, P Evans, L Wyld |
| Abstract |
Gene expression profiling (GEP) and expanded immunohistochemistry (IHC) tests aim to improve decision-making relating to adjuvant chemotherapy for women with early breast cancer. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 182 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 1% |
| Italy | 1 | <1% |
| Chile | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 176 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 36 | 20% |
| Other | 21 | 12% |
| Student > Master | 21 | 12% |
| Student > Ph. D. Student | 18 | 10% |
| Student > Bachelor | 14 | 8% |
| Other | 39 | 21% |
| Unknown | 33 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 70 | 38% |
| Biochemistry, Genetics and Molecular Biology | 13 | 7% |
| Agricultural and Biological Sciences | 13 | 7% |
| Nursing and Health Professions | 9 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Other | 23 | 13% |
| Unknown | 45 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2018.
All research outputs
#8,262,981
of 25,377,790 outputs
Outputs from Health technology assessment : HTA / NHS R & D HTA Programme.
#843
of 1,235 outputs
Outputs of similar age
#71,850
of 219,859 outputs
Outputs of similar age from Health technology assessment : HTA / NHS R & D HTA Programme.
#11
of 15 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 1,235 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 219,859 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.